Parties in lawsuits have to turn over relevant information to the other side in lawsuits like this one
A systematic review indicated that patients treated with GLP-1RAs had a significantly lower risk of incident HCC compared to those receiving other antidiabetic medications, such as insulin and sulfonylureas (Sha et al., 2024)
Surging youth adoption brings cost concerns If an ever-growing number of patients adopt GLP-1s early and rely on them for life, the burden of cost could prove unsustainable for health plans and employers
However, they should be prescribed with caution in patients with cardiovascular disease, and certain contraindications apply, particularly concurrent use of nitrates
Persistent, patchy, or scarring hair loss is never "just" GLP-1-related shedding and always warrants an in-person evaluation to rule out alopecia areata, scalp psoriasis, or thyroid-related alopecia